Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma

Lung, Respiratory and Thoracic CancerRadio-Oncology

Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting

J Thorac Oncol.

Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK

doi: 10.1016/j.jtho.2019.08.012.

Lymphoma

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

J Clin Oncol.

Barrington SF, Phillips EH, Counsell N, Hancock B, Pettengell R, Johnson P, Townsend W, Culligan D, Popova B, Clifton-Hadley L, McMillan A, Hoskin P, O'Doherty MJ, Illidge T, Radford J

doi: 10.1200/JCO.18.01799.

Lung, Respiratory and Thoracic Cancer

State of the Art: Advances in Malignant Pleural Mesothelioma in 2017

J Thorac Oncol.

McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T

doi: 10.1016/j.jtho.2018.02.021.

Lung, Respiratory and Thoracic Cancer

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial

JAMA Oncol.

Szlosarek PW, Steele JP, Nolan L, Gilligan D, Taylor P, Spicer J, Lind M, Mitra S, Shamash J, Phillips MM, Luong P, Payne S, Hillman P, Ellis S, Szyszko T, Dancey G, Butcher L, Beck S, Avril NE, Thomson J, Johnston A, Tomsa M, Lawrence C, Schmid P, Crook T, Wu BW, Bomalaski JS, Lemoine N, Sheaff MT, Rudd RM, Fennell D, Hackshaw A

doi: 10.1001/

Lung, Respiratory and Thoracic Cancer

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

J Thorac Oncol.

Kao SC, Cheng YY, Williams M, Kirschner MB, Madore J, Lum T, Sarun KH, Linton A, McCaughan B, Klebe S, van Zandwijk N, Scolyer RA, Boyer MJ, Cooper WA, Reid G

doi: 10.1016/j.jtho.2017.05.024.

Progress in the Management of Malignant Pleural Mesothelioma in 2017

J Thorac Oncol.

McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M0, Yang H, Peikert T

doi: 10.1016/j.jtho.2018.02.021.

Skin CancerMultiple Myeloma (MM)

An integrated clinical and dermoscopic risk scoring system (iDScore) for the differentiation between early melanoma and atypical nevi

J Eur Acad Dermatol Venereol.

Tognetti L, Cevenini G, Moscarella E, Cinotti E, Farnetani F, Mahlvey J, Perrot JL, Longo C, Pellacani G, Argenziano G, Fimiani M, Rubegni P

doi: 10.1111/jdv.15106.

Lung, Respiratory and Thoracic Cancer

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

BMC Cancer.

Collins DC, Sundar R, Constantidinou A, Dolling D, Yap TA, Popat S, O'Brien ME, Banerji U, de Bono JS, Lopez JS, Tunariu N, Minchom A

doi: 10.1186/s12885-020-07662-y.

WCLC 2020

Lung, Respiratory and Thoracic Cancer

Malignant Mesothelioma

Fennel D et al. 2021. Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial. Oral presentation presented at: WCLC 2020; 28−31 January 2021.

Related content

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

State of the Art: Advances in Malignant Pleural Mesothelioma in 2017

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Progress in the Management of Malignant Pleural Mesothelioma in 2017

An integrated clinical and dermoscopic risk scoring system (iDScore) for the differentiation between early melanoma and atypical nevi

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease

Malignant Mesothelioma